Case Page

 

Case Status:    DISMISSED    
On or around 10/25/2017 (Notice of voluntarily dismissal)

Filing Date: October 20, 2017

According to the Complaint, this action stems from a proposed transaction announced on September 27, 2017 (the “Proposed Transaction”), pursuant to which Alcobra Ltd. (“Alcobra” or the “Company”) will merge with Arcturus Therapeutics, Inc. (“Arcturus”) in an all-stock transaction.

On September 27, 2017, Alcobra’s Board of Directors (the “Board” or “Individual Defendants”) caused the Company to enter into an agreement and plan of merger (the “Merger Agreement”) with Arcturus and Aleph Mergersub Inc. (“Merger Sub”).

On September 28, 2017, Alcobra filed two Form 6-Ks with the United States Securities and Exchange Commission (“SEC”) in connection with the Proposed Transaction. To date, Alcobra has not filed a proxy statement or proxy card with the SEC in connection with the Proposed Transaction, and plaintiff has not received a proxy statement or proxy card by mail. Accordingly, plaintiff seeks to enjoin the November 2, 2017 Stockholder Vote on the Proposed Transaction, as stockholders cannot make an informed decision with respect to the
merger without a proxy statement.

On October 25, 2017, this case was voluntarily dismissed.

COMPANY INFORMATION:

Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: Israel

SECURITIES INFORMATION:

Ticker Symbol: ADHD
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: E.D. Pennsylvania
DOCKET #: 17-CV-04692
JUDGE: Hon. Jan E. Dubois
DATE FILED: 10/20/2017
CLASS PERIOD START: 09/27/2017
CLASS PERIOD END: 10/20/2017
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Law Offices of Marc S. Henzel
    5 431 Montgomery Avenue, Suite B, Law Offices of Marc S. Henzel, PA 19066
    610-660-8000 ·
  2. Profy Promisloff & Ciarlanto, P.C.
    100 N. 22nd Street, Unit 105 , Profy Promisloff & Ciarlanto, P.C. , PA 19087
    215-259-5156 215-600-2642 ·
  3. Rigrodsky & Long, P.A.
    919 N. Market Street, Suite 980, Rigrodsky & Long, P.A., DE 19803
    302.295.5310 302.295.5310 · info@rigrodskylong.com
No Document Title Filing Date